Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0532 Transporter Info
Gene Name	KCNT1
Transporter Name	Potassium channel subfamily T member 1
Gene ID	57582
UniProt ID	Q9P2C5

Post-Translational Modification of This DT
Overview of KCNT1 Modification Sites with Functional and Structural Information
Sequence	M A R A K L P R S P S E G K A G P G G A P A G A A A P E E P H G L S P L L P A R G G G S V G S D V G Q R L P V E D F S L D S S L S Q V Q V E F Y V N E N T F K E R L K L F F I K N Q R S S L R I R L F N F S L K L L T C L L Y I V R V L L D D P A L G I G C W G C P K Q N Y S F N D S S S E I N W A P I L W V E R K M T L W A I Q V I V A I I S F L E T M L L I Y L S Y K G N I W E Q I F R V S F V L E M I N T L P F I I T I F W P P L R N L F I P V F L N C W L A K H A L E N M I N D F H R A I L R T Q S A M F N Q V L I L F C T L L C L V F T G T C G I Q H L E R A G E N L S L L T S F Y F C I V T F S T V G Y G D V T P K I W P S Q L L V V I M I C V A L V V L P L Q F E E L V Y L W M E R Q K S G G N Y S R H R A Q T E K H V V L C V S S L K I D L L M D F L N E F Y A H P R L Q D Y Y V V I L C P T E M D V Q V R R V L Q I P L W S Q R V I Y L Q G S A L K D Q D L M R A K M D N G E A C F I L S S R N E V D R T A A D H Q T I L R A W A V K D F A P N C P L Y V Q I L K P E N K F H V K F A D H V V C E E E C K Y A M L A L N C I C P A T S T L I T L L V H T S R G Q E G Q E S P E Q W Q R M Y G R C S G N E V Y H I R M G D S K F F R E Y E G K S F T Y A A F H A H K K Y G V C L I G L K R E D N K S I L L N P G P R H I L A A S D T C F Y I N I T K E E N S A F I F K Q E E K R K K R A F S G Q G L H E G P A R L P V H S I I A S M G T V A M D L Q G T E H R P T Q S G G G G G G S K L A L P T E N G S G S R R P S I A P V L E L A D S S A L L P C D L L S D Q S E D E V T P S D D E G L S V V E Y V K G Y P P N S P Y I G S S P T L C H L L P V K A P F C C L R L D K G C K H N S Y E D A K A Y G F K N K L I I V S A E T A G N G L Y N F I V P L R A Y Y R S R K E L N P I V L L L D N K P D H H F L E A I C C F P M V Y Y M E G S V D N L D S L L Q C G I I Y A D N L V V V D K E S T M S A E E D Y M A D A K T I V N V Q T M F R L F P S L S I T T E L T H P S N M R F M Q F R A K D S Y S L A L S K L E K R E R E N G S N L A F M F R L P F A A G R V F S I S M L D T L L Y Q S F V K D Y M I T I T R L L L G L D T T P G S G Y L C A M K I T E G D L W I R T Y G R L F Q K L C S S S A E I P I G I Y R T E S H V F S T S E S Q I S V N V E D C E D T R E V K G P W G S R A G T G G S S Q G R H T G G G D P A E H P L L R R K S L Q W A R R L S R K A P K Q A G R A A A A E W I S Q Q R L S L Y R R S E R Q E L S E L V K N R M K H L G L P T T G Y E D V A N L T A S D V M N R V N L G Y L Q D E M N D H Q N T L S Y V L I N P P P D T R L E P S D I V Y L I R S D P L A H V A S S S Q S R K S S C S H K L S S C N P E T R D E T Q L
PTM type	X-Acetylation X-Methylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at KCNT1 Lysine 79 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence KCNT1			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	580
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at KCNT1 Lysine 580 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence KCNT1			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	966
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at KCNT1 Lysine 966 has the potential to affect its expression or activity.
Methylation
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[4]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	1080
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at KCNT1 Arginine 1080 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at KCNT1 Asparagine 133 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence KCNT1			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at KCNT1 Asparagine 137 has the potential to affect its expression or activity.
Phosphorylation
Serine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence KCNT1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	11
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 11 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence KCNT1			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	92
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 92 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence KCNT1			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	93
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 93 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence KCNT1			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	438
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 438 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence KCNT1			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	439
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 439 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence KCNT1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	630
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 630 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence KCNT1			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	645
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 645 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence KCNT1			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	963
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 963 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence KCNT1			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1083
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 1083 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence KCNT1			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1218
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 1218 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence KCNT1			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1219
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Serine 1219 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	609
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Threonine 609 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence KCNT1			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	665
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Threonine 665 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence KCNT1			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	680
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Threonine 680 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence KCNT1			[16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	572
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 Tyrosine 572 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the activity of KCNT1			[17]
Role of PTM	Protein Activity Modulation
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at KCNT1 have been reported to enhance its transport activity.

References
1	Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia. J Manag Care Spec Pharm. 2019 Jan;25(1):37-46.
2	Extreme heat and cultural and linguistic minorities in Australia: perceptions of stakeholders. BMC Public Health. 2014 Jun 3;14:550.
3	Breast reconstruction after mastectomy: problems in position, size, and shape. Plast Reconstr Surg. 1980 May;65(5):595-602.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: KCNT1_HUMAN)
5	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
6	Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction. J Proteomics. 2017 Aug 8;165:69-74.
7	Phosphoproteomics of MAPK inhibition in BRAF-mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition. Mol Cancer Ther. 2014 Jul;13(7):1894-906.
8	Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
11	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
12	Environmental stress affects the activity of metabolic and growth factor signaling networks and induces autophagy markers in MCF7 breast cancer cells. Mol Cell Proteomics. 2014 Mar;13(3):836-48.
13	Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
14	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
15	Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.
16	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
17	UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: Q5JUK3)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence